Since serous ovarian cancer is the main type of ovarian cancer, we separately analyzed the relationship between CRABP2 and the prognosis of serous ovarian cancer patients, and found that CRABP2 was also a risk factor for OS and PFS in serous ovarian cancer patients (Fig. S1E and F). Here, CRABP2 is linked to ovarian serous adenocarcinoma.